FDA Tries to Clear Up Continuous Manufacturing Ambiguities
This article was originally published in The Gold Sheet
Executive Summary
FDA seeks “creative” solutions to clear up the regulatory ambiguities associated with continuous manufacturing. Agency also notes “teething problems” with continuous manufacturing implementation.